An Electrocardiogram Study to Evaluate the Effect of Vanzacaftor on the QT/QTc Interval in Healthy Participants
Clinical trial NCT05867147 · COMPLETED
Trial details
- NCT number
- NCT05867147
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-26
- Primary completion
- 2023-06-14
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.